Stroke poses a serious threat to human health and burdens both society and the healthcare
system. Standard rehabilitative therapies may not be effective in improving functions after …

Vagus nerve stimulation (VNS) is currently Food and Drug Administration-approved for
treatment of both medically refractory partial-onset seizures and severe, recurrent refractory …

Stroke seriously endangers human well-being and brings a severe burden to family and
society. Different post-stroke dysfunctions result in an impaired ability to perform activities of …

The efficacy of standard rehabilitative therapy for improving upper limb functions after stroke
is limited; thus, alternative strategies are needed. Vagus nerve stimulation (VNS) paired with …

Introduction: Recent randomized controlled trials (RCTs) have assessed the role of vagus
nerve stimulation (VNS) when paired with standard rehabilitation in stroke patients. This …

Background Secondary damage due to neurochemical and inflammatory changes in the
penumbra in the first days after ischemic stroke contributes substantially to poor clinical …

Background Non-invasive vagus nerve stimulation (nVNS) using a hand-held stimulator
placed on the neck is an FDA-approved treatment for primary headache disorders. The …

Abstract The Food and Drug Administration has approved vagus-nerve stimulation (VNS) for
the treatment of patients with epilepsy, depression, and headache. By targeting diverse …

Stroke is one of the leading causes of death and disability globally. A significant proportion
of stroke survivors are left with long term neurological deficits that have a detrimental effect …

Stroke is a leading cause of disability worldwide, and in approximately 60% of individuals,
upper limb deficits persist 6 months after stroke. These deficits adversely affect the functional …